{
    "organizations": [],
    "uuid": "7042b92d1aff107337454c64fb0daa7736bcbf26",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-richter-sees-over-50-pct-esmya-sal/brief-richter-sees-over-50-pct-esmya-sales-fall-in-2018-ceo-idUSL8N1Q21K8",
    "ord_in_thread": 0,
    "title": "BRIEF-Richter sees over 50 pct Esmya sales fall in 2018 -CEO",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 12 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt CEO Gabor Orban tells press conference:\n* EXPECTS MORE THAN 50 PERCENT SALES DECLINE OF ITS UTERINE FIBROID MEDICINE ESMYA IN 2018\n* RICHTER AIMS TO COOPERATE FULLY WITH EUROPEAN REGULATORS IN PROBE OF ESMYA, NOT CONSIDERING ANY LEGAL COUNTERSTEPS AT THIS POINT\n* ESMYA GLOBAL RIGHTS LISTED AMONG COMPANYâ€˜S ASSETS, WILL BE REVALUED DOWNWARDS AND REFLECTED IN AUDITED BALANCE SHEET TO BE PUBLISHED LATER\n* ESMYA PROBE MIGHT AFFECT COMPANY VALUE THROUGH OUTLOOK OF U.S. REGULATORY APPROVAL PROCESS, LONG-TERM REVENUE AND EARNINGS OUTLOOK Further company coverage: (Reporting by Marton Dunai)\n ",
    "published": "2018-02-12T16:46:00.000+02:00",
    "crawled": "2018-02-13T16:00:37.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "richter",
        "gedeon",
        "vegyeszeti",
        "gyar",
        "nyrt",
        "ceo",
        "gabor",
        "orban",
        "tell",
        "press",
        "conference",
        "expects",
        "percent",
        "sale",
        "decline",
        "uterine",
        "fibroid",
        "medicine",
        "esmya",
        "richter",
        "aim",
        "cooperate",
        "fully",
        "european",
        "regulator",
        "probe",
        "esmya",
        "considering",
        "legal",
        "countersteps",
        "point",
        "esmya",
        "global",
        "right",
        "listed",
        "among",
        "company",
        "asset",
        "revalued",
        "downwards",
        "reflected",
        "audited",
        "balance",
        "sheet",
        "published",
        "later",
        "esmya",
        "probe",
        "might",
        "affect",
        "company",
        "value",
        "outlook",
        "regulatory",
        "approval",
        "process",
        "revenue",
        "earnings",
        "outlook",
        "company",
        "coverage",
        "reporting",
        "marton",
        "dunai"
    ]
}